Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.

Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cases. We aimed to study the frequency and relationship of a wide range of genes previously reported as mutated in AML (ASXL1, NPM1, FLT3, TET2, IDH1/2, RUNX1, DNMT3A, NRAS, JAK2, WT1, CBL, SF3B1, TP53,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Fernandez-Mercado, Bon Ham Yip, Andrea Pellagatti, Carwyn Davies, María José Larrayoz, Toshinori Kondo, Cristina Pérez, Sally Killick, Emma-Jane McDonald, María Dolores Odero, Xabier Agirre, Felipe Prósper, María José Calasanz, James S Wainscoat, Jacqueline Boultwood
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6cfaed15b9bf4c11b08ee7dfcacf1fde
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6cfaed15b9bf4c11b08ee7dfcacf1fde
record_format dspace
spelling oai:doaj.org-article:6cfaed15b9bf4c11b08ee7dfcacf1fde2021-11-18T07:09:14ZMutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.1932-620310.1371/journal.pone.0042334https://doaj.org/article/6cfaed15b9bf4c11b08ee7dfcacf1fde2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22912701/?tool=EBIhttps://doaj.org/toc/1932-6203Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cases. We aimed to study the frequency and relationship of a wide range of genes previously reported as mutated in AML (ASXL1, NPM1, FLT3, TET2, IDH1/2, RUNX1, DNMT3A, NRAS, JAK2, WT1, CBL, SF3B1, TP53, KRAS and MPL) in a series of 84 CN-AML cases. The most frequently mutated genes in primary cases were NPM1 (60.8%) and FLT3 (50.0%), and in secondary cases ASXL1 (48.5%) and TET2 (30.3%). We showed that 85% of CN-AML patients have mutations in at least one of ASXL1, NPM1, FLT3, TET2, IDH1/2 and/or RUNX1. Serial samples from 19 MDS/CMML cases that progressed to AML were analyzed for ASXL1/TET2/IDH1/2 mutations; seventeen cases presented mutations of at least one of these genes. However, there was no consistent pattern in mutation acquisition during disease progression. This report concerns the analysis of the largest number of gene mutations in CN-AML studied to date, and provides insight into the mutational profile of CN-AML.Marta Fernandez-MercadoBon Ham YipAndrea PellagattiCarwyn DaviesMaría José LarrayozToshinori KondoCristina PérezSally KillickEmma-Jane McDonaldMaría Dolores OderoXabier AgirreFelipe PrósperMaría José CalasanzJames S WainscoatJacqueline BoultwoodPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 8, p e42334 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marta Fernandez-Mercado
Bon Ham Yip
Andrea Pellagatti
Carwyn Davies
María José Larrayoz
Toshinori Kondo
Cristina Pérez
Sally Killick
Emma-Jane McDonald
María Dolores Odero
Xabier Agirre
Felipe Prósper
María José Calasanz
James S Wainscoat
Jacqueline Boultwood
Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
description Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cases. We aimed to study the frequency and relationship of a wide range of genes previously reported as mutated in AML (ASXL1, NPM1, FLT3, TET2, IDH1/2, RUNX1, DNMT3A, NRAS, JAK2, WT1, CBL, SF3B1, TP53, KRAS and MPL) in a series of 84 CN-AML cases. The most frequently mutated genes in primary cases were NPM1 (60.8%) and FLT3 (50.0%), and in secondary cases ASXL1 (48.5%) and TET2 (30.3%). We showed that 85% of CN-AML patients have mutations in at least one of ASXL1, NPM1, FLT3, TET2, IDH1/2 and/or RUNX1. Serial samples from 19 MDS/CMML cases that progressed to AML were analyzed for ASXL1/TET2/IDH1/2 mutations; seventeen cases presented mutations of at least one of these genes. However, there was no consistent pattern in mutation acquisition during disease progression. This report concerns the analysis of the largest number of gene mutations in CN-AML studied to date, and provides insight into the mutational profile of CN-AML.
format article
author Marta Fernandez-Mercado
Bon Ham Yip
Andrea Pellagatti
Carwyn Davies
María José Larrayoz
Toshinori Kondo
Cristina Pérez
Sally Killick
Emma-Jane McDonald
María Dolores Odero
Xabier Agirre
Felipe Prósper
María José Calasanz
James S Wainscoat
Jacqueline Boultwood
author_facet Marta Fernandez-Mercado
Bon Ham Yip
Andrea Pellagatti
Carwyn Davies
María José Larrayoz
Toshinori Kondo
Cristina Pérez
Sally Killick
Emma-Jane McDonald
María Dolores Odero
Xabier Agirre
Felipe Prósper
María José Calasanz
James S Wainscoat
Jacqueline Boultwood
author_sort Marta Fernandez-Mercado
title Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
title_short Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
title_full Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
title_fullStr Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
title_full_unstemmed Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
title_sort mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (aml) with normal cytogenetics.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/6cfaed15b9bf4c11b08ee7dfcacf1fde
work_keys_str_mv AT martafernandezmercado mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT bonhamyip mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT andreapellagatti mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT carwyndavies mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT mariajoselarrayoz mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT toshinorikondo mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT cristinaperez mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT sallykillick mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT emmajanemcdonald mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT mariadoloresodero mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT xabieragirre mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT felipeprosper mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT mariajosecalasanz mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT jamesswainscoat mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
AT jacquelineboultwood mutationpatternsof16genesinprimaryandsecondaryacutemyeloidleukemiaamlwithnormalcytogenetics
_version_ 1718423856974135296